ALVARO TAMAYO VELASCO-rekin lankidetzan egindako argitalpenak (23)

2024

  1. COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study

    Journal of Infection and Public Health, Vol. 17, Núm. 6, pp. 939-946

  2. Epidemiology of fungal infection in COVID 19 in Spain during 2020 and 2021: a nationwide study

    Scientific Reports, Vol. 14, Núm. 1

  3. MiRNome Profiling of Extracellular Vesicles in Patients with Severe COVID-19 and Identification of Predictors of Mortality

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. 901-911

  4. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Environmental factors are associated to hospital outcomes in COVID-19 patients during lockdown and post-lockdown in 2020: A nationwide study

    Environmental Research, Vol. 229

  3. Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study

    European journal of public health, Vol. 33, Núm. 4, pp. 675-681

2022

  1. Dyslipidemia and Inflammation as Hallmarks of Oxidative Stress in COVID-19: A Follow-Up Study

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  2. Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality

    Critical Care, Vol. 26, Núm. 1

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. PCR-based diagnosis of respiratory virus in postsurgical septic patients: A preliminary study before SARS-CoV-2 pandemic

    Medicine (United States), Vol. 101, Núm. 32, pp. E29902

  5. Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients

    Frontiers in Immunology, Vol. 13

2021

  1. Can the Cytokine Profile According to ABO Blood Groups Be Related to Worse Outcome in COVID-19 Patients? Yes, They Can

    Frontiers in Immunology, Vol. 12

  2. Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients

    Journal of Headache and Pain, Vol. 22, Núm. 1

  3. Distinguishing septic shock from non-septic shock in postsurgical patients using gene expression

    Journal of Infection, Vol. 83, Núm. 2, pp. 147-155

  4. Endothelial dysfunction and neutrophil degranulation as central events in sepsis physiopathology

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

  5. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  6. Genetic susceptibility to acute kidney injury

    Journal of Clinical Medicine, Vol. 10, Núm. 14

  7. HGF, IL-1α, and IL-27 are robust biomarkers in early severity stratification of COVID-19 patients

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  8. Lipid peroxidation as a hallmark of severity in COVID-19 patients

    Redox Biology, Vol. 48